Novo Nordisk A S NVO
NYSE NVO
$46.74 +0.60 (+1.30%)
At close: Aug 21, 2026 · 4:02 PM EDT

Novo Nordisk A S (NVO) Cost of Revenue (2012 - 2016)

Novo Nordisk A S's (NVO) quarterly Cost of Revenue came in at $614.0 million in Q2 2016, up 7.72% YoY from $570.0 million in Q3 2015, and down 1.76% on a QoQ basis from $625.0 million in Q1 2016.

Novo Nordisk A S (NVO) Cost of Revenue (2012 - 2016) Analysis & Trends

Novo Nordisk A S (NVO) has 5 years of Cost of Revenue data on file, last reported at $614.0 million in Q2 2016.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2016 614.00 Mn
Jun 30, 2016 614.00 Mn
Mar 31, 2016 625.00 Mn
Mar 31, 2016 625.00 Mn
Dec 31, 2015 678.00 Mn
Dec 31, 2015 678.00 Mn
Sep 30, 2015 573.00 Mn
Sep 30, 2015 573.00 Mn
Jun 30, 2015 570.00 Mn
Jun 30, 2015 570.00 Mn
Mar 31, 2015 586.00 Mn
Mar 31, 2015 586.00 Mn
Dec 31, 2014 674.00 Mn
Dec 31, 2014 674.00 Mn
Sep 30, 2014 608.00 Mn
Sep 30, 2014 608.00 Mn
Jun 30, 2014 674.00 Mn
Jun 30, 2014 674.00 Mn
Mar 31, 2014 637.00 Mn
Mar 31, 2014 637.00 Mn